US Stock MarketDetailed Quotes

UTHR United Therapeutics

Watchlist
  • 368.790
  • -1.330-0.36%
Close Dec 3 16:00 ET
  • 368.790
  • 0.0000.00%
Post 20:01 ET
16.46BMarket Cap16.20P/E (TTM)

United Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
8.95%377.2M
118.44%232.2M
0.45%376.5M
21.87%978M
17.55%150.7M
33.87%346.2M
-16.30%106.3M
29.82%374.8M
34.15%802.5M
-26.58%128.2M
Net income from continuing operations
15.51%309.1M
7.29%278.1M
27.27%306.6M
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
52.86%727.3M
17.74%132.1M
Operating gains losses
----
----
----
----
----
----
----
----
92.33%-7.1M
-785.71%-6.2M
Depreciation and amortization
43.61%19.1M
44.96%18.7M
12.78%15M
3.70%53.2M
3.79%13.7M
3.10%13.3M
1.57%12.9M
6.40%13.3M
2.81%51.3M
4.76%13.2M
Other non cash items
-216.67%-5.7M
-41.03%-5.5M
-281.03%-10.5M
-109.33%-4.9M
-163.29%-5M
-118.00%-1.8M
-108.33%-3.9M
147.54%5.8M
-20.33%52.5M
-79.16%7.9M
Change In working capital
-71.74%13M
39.32%-108.8M
-68.71%39.8M
30.74%-97.8M
-4.44%-91.7M
730.14%46M
-57.28%-179.3M
87.33%127.2M
18.94%-141.2M
-165.26%-87.8M
-Change in receivables
-465.00%-51.1M
111.95%16.5M
-132.95%-28.3M
-169.59%-58.5M
-279.65%-20.3M
124.01%14M
-4,832.14%-138.1M
205.69%85.9M
47.46%-21.7M
-19.86%11.3M
-Change in inventory
-264.52%-11.3M
-1,370.00%-14.7M
-272.00%-9.3M
-1.49%-13.6M
49.64%-7M
-416.67%-3.1M
78.26%-1M
-143.86%-2.5M
-78.67%-13.4M
-13,800.00%-13.9M
-Change in payables and accrued expense
-16.24%33M
-32.11%25.8M
-32.14%1.9M
28.31%57.1M
-353.85%-23.1M
76.68%39.4M
59.00%38M
125.93%2.8M
456.00%44.5M
126.38%9.1M
-Change in other working capital
1,086.05%42.4M
-74.42%-136.4M
84.15%75.5M
45.02%-82.8M
56.20%-41.3M
-114.68%-4.3M
40.08%-78.2M
-8.69%41M
-33.39%-150.6M
-648.41%-94.3M
Cash from discontinued investing activities
Operating cash flow
8.95%377.2M
118.44%232.2M
0.45%376.5M
21.87%978M
17.55%150.7M
33.87%346.2M
-16.30%106.3M
29.82%374.8M
34.15%802.5M
-26.58%128.2M
Investing cash flow
Cash flow from continuing investing activities
63.34%-114.9M
64.79%-80M
432.56%735.3M
11.32%-719.6M
122.24%42.1M
-233.40%-313.4M
-34.44%-227.2M
38.45%-221.1M
-66.67%-811.5M
3.32%-189.3M
Net PPE purchase and sale
-16.44%-76.5M
-0.89%-45.1M
7.51%-38.2M
-65.99%-230.4M
-99.24%-78.7M
4.51%-65.7M
-162.94%-44.7M
-205.93%-41.3M
-14.90%-138.8M
44.05%-39.5M
Net business purchase and sale
--0
----
----
---89.2M
-6,046.67%-89.2M
--0
----
----
--0
--1.5M
Net investment purchase and sale
91.31%-20.6M
80.98%-34M
532.59%777.8M
44.25%-377M
241.28%218.7M
-900.42%-237.1M
-17.63%-178.8M
47.99%-179.8M
-84.70%-676.2M
-23.64%-154.8M
Net other investing changes
-67.92%-17.8M
---400K
---4.3M
-757.14%-23M
---8.7M
---10.6M
----
----
--3.5M
----
Cash from discontinued investing activities
Investing cash flow
63.34%-114.9M
64.79%-80M
432.56%735.3M
11.32%-719.6M
122.24%42.1M
-233.40%-313.4M
-34.44%-227.2M
38.45%-221.1M
-66.67%-811.5M
3.32%-189.3M
Financing cash flow
Cash flow from continuing financing activities
-943.42%-64.1M
-294.33%-48M
-2,297.53%-1.07B
-115.78%-11.9M
-267.21%-92.8M
8.57%7.6M
3.35%24.7M
541.82%48.6M
68.30%75.4M
640.00%55.5M
Net issuance payments of debt
---100M
---100M
---100M
---100M
---100M
--0
--0
--0
--0
--0
Net common stock issuance
-100.00%-400K
14.81%-11.5M
---1B
-21.05%-13.8M
---100K
33.33%-200K
---13.5M
--0
-5.56%-11.4M
--0
Proceeds from stock option exercised by employees
365.38%36.3M
110.93%52.1M
-28.86%46.1M
10.92%104.6M
-86.85%7.3M
6.85%7.8M
3.35%24.7M
752.63%64.8M
69.60%94.3M
620.78%55.5M
Net other financing activities
--0
-15.56%11.4M
12.96%-14.1M
64.00%-2.7M
--0
--0
--13.5M
-116.00%-16.2M
---7.5M
--0
Cash from discontinued financing activities
Financing cash flow
-943.42%-64.1M
-294.33%-48M
-2,297.53%-1.07B
-115.78%-11.9M
-267.21%-92.8M
8.57%7.6M
3.35%24.7M
541.82%48.6M
68.30%75.4M
640.00%55.5M
Net cash flow
Beginning cash position
27.02%1.36B
7.56%1.25B
25.65%1.21B
7.42%961.2M
14.57%1.11B
34.22%1.07B
43.06%1.16B
7.42%961.2M
21.13%894.8M
6.42%966.8M
Current changes in cash
390.59%198.2M
208.32%104.2M
-78.35%43.8M
271.23%246.5M
1,885.71%100M
-76.46%40.4M
-431.49%-96.2M
348.22%202.3M
-57.46%66.4M
59.12%-5.6M
End cash Position
40.28%1.55B
27.02%1.36B
7.56%1.25B
25.65%1.21B
25.65%1.21B
14.57%1.11B
34.22%1.07B
43.06%1.16B
7.42%961.2M
7.42%961.2M
Free cash flow
7.20%300.7M
203.73%187.1M
1.44%338.3M
12.64%747.6M
-18.83%72M
47.79%280.5M
-44.00%61.6M
21.18%333.5M
39.02%663.7M
-14.71%88.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 8.95%377.2M118.44%232.2M0.45%376.5M21.87%978M17.55%150.7M33.87%346.2M-16.30%106.3M29.82%374.8M34.15%802.5M-26.58%128.2M
Net income from continuing operations 15.51%309.1M7.29%278.1M27.27%306.6M35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M52.86%727.3M17.74%132.1M
Operating gains losses --------------------------------92.33%-7.1M-785.71%-6.2M
Depreciation and amortization 43.61%19.1M44.96%18.7M12.78%15M3.70%53.2M3.79%13.7M3.10%13.3M1.57%12.9M6.40%13.3M2.81%51.3M4.76%13.2M
Other non cash items -216.67%-5.7M-41.03%-5.5M-281.03%-10.5M-109.33%-4.9M-163.29%-5M-118.00%-1.8M-108.33%-3.9M147.54%5.8M-20.33%52.5M-79.16%7.9M
Change In working capital -71.74%13M39.32%-108.8M-68.71%39.8M30.74%-97.8M-4.44%-91.7M730.14%46M-57.28%-179.3M87.33%127.2M18.94%-141.2M-165.26%-87.8M
-Change in receivables -465.00%-51.1M111.95%16.5M-132.95%-28.3M-169.59%-58.5M-279.65%-20.3M124.01%14M-4,832.14%-138.1M205.69%85.9M47.46%-21.7M-19.86%11.3M
-Change in inventory -264.52%-11.3M-1,370.00%-14.7M-272.00%-9.3M-1.49%-13.6M49.64%-7M-416.67%-3.1M78.26%-1M-143.86%-2.5M-78.67%-13.4M-13,800.00%-13.9M
-Change in payables and accrued expense -16.24%33M-32.11%25.8M-32.14%1.9M28.31%57.1M-353.85%-23.1M76.68%39.4M59.00%38M125.93%2.8M456.00%44.5M126.38%9.1M
-Change in other working capital 1,086.05%42.4M-74.42%-136.4M84.15%75.5M45.02%-82.8M56.20%-41.3M-114.68%-4.3M40.08%-78.2M-8.69%41M-33.39%-150.6M-648.41%-94.3M
Cash from discontinued investing activities
Operating cash flow 8.95%377.2M118.44%232.2M0.45%376.5M21.87%978M17.55%150.7M33.87%346.2M-16.30%106.3M29.82%374.8M34.15%802.5M-26.58%128.2M
Investing cash flow
Cash flow from continuing investing activities 63.34%-114.9M64.79%-80M432.56%735.3M11.32%-719.6M122.24%42.1M-233.40%-313.4M-34.44%-227.2M38.45%-221.1M-66.67%-811.5M3.32%-189.3M
Net PPE purchase and sale -16.44%-76.5M-0.89%-45.1M7.51%-38.2M-65.99%-230.4M-99.24%-78.7M4.51%-65.7M-162.94%-44.7M-205.93%-41.3M-14.90%-138.8M44.05%-39.5M
Net business purchase and sale --0-----------89.2M-6,046.67%-89.2M--0----------0--1.5M
Net investment purchase and sale 91.31%-20.6M80.98%-34M532.59%777.8M44.25%-377M241.28%218.7M-900.42%-237.1M-17.63%-178.8M47.99%-179.8M-84.70%-676.2M-23.64%-154.8M
Net other investing changes -67.92%-17.8M---400K---4.3M-757.14%-23M---8.7M---10.6M----------3.5M----
Cash from discontinued investing activities
Investing cash flow 63.34%-114.9M64.79%-80M432.56%735.3M11.32%-719.6M122.24%42.1M-233.40%-313.4M-34.44%-227.2M38.45%-221.1M-66.67%-811.5M3.32%-189.3M
Financing cash flow
Cash flow from continuing financing activities -943.42%-64.1M-294.33%-48M-2,297.53%-1.07B-115.78%-11.9M-267.21%-92.8M8.57%7.6M3.35%24.7M541.82%48.6M68.30%75.4M640.00%55.5M
Net issuance payments of debt ---100M---100M---100M---100M---100M--0--0--0--0--0
Net common stock issuance -100.00%-400K14.81%-11.5M---1B-21.05%-13.8M---100K33.33%-200K---13.5M--0-5.56%-11.4M--0
Proceeds from stock option exercised by employees 365.38%36.3M110.93%52.1M-28.86%46.1M10.92%104.6M-86.85%7.3M6.85%7.8M3.35%24.7M752.63%64.8M69.60%94.3M620.78%55.5M
Net other financing activities --0-15.56%11.4M12.96%-14.1M64.00%-2.7M--0--0--13.5M-116.00%-16.2M---7.5M--0
Cash from discontinued financing activities
Financing cash flow -943.42%-64.1M-294.33%-48M-2,297.53%-1.07B-115.78%-11.9M-267.21%-92.8M8.57%7.6M3.35%24.7M541.82%48.6M68.30%75.4M640.00%55.5M
Net cash flow
Beginning cash position 27.02%1.36B7.56%1.25B25.65%1.21B7.42%961.2M14.57%1.11B34.22%1.07B43.06%1.16B7.42%961.2M21.13%894.8M6.42%966.8M
Current changes in cash 390.59%198.2M208.32%104.2M-78.35%43.8M271.23%246.5M1,885.71%100M-76.46%40.4M-431.49%-96.2M348.22%202.3M-57.46%66.4M59.12%-5.6M
End cash Position 40.28%1.55B27.02%1.36B7.56%1.25B25.65%1.21B25.65%1.21B14.57%1.11B34.22%1.07B43.06%1.16B7.42%961.2M7.42%961.2M
Free cash flow 7.20%300.7M203.73%187.1M1.44%338.3M12.64%747.6M-18.83%72M47.79%280.5M-44.00%61.6M21.18%333.5M39.02%663.7M-14.71%88.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.